1. Introduction {#sec1-molecules-21-01146}
===============

Celastraceae is a large family comprising about 97 genera and 1194 species, which are distributed mainly in the tropics and subtropics. Among them, 14 genera with 192 species are native to China \[[@B1-molecules-21-01146]\]. Some plants from several genera including *Tripterygium*, *Celastrus*, *Euonymus*, and *Maytenus*, are used as folk medicines or traditional Chinese medicines \[[@B1-molecules-21-01146],[@B2-molecules-21-01146]\]. Plants of this family are the richest source of diverse dihydro-β-agarofuran sesquiterpenoids, which have been considered as characteristic metabolites and chemotaxonomic markers of this family \[[@B3-molecules-21-01146],[@B4-molecules-21-01146]\]. This class of sesquiterpenes has attracted researchers' interest because of a variety of promising bioactivities, such as anti-inflammatory, immunosuppressive, multidrug resistance reversal, cytotoxic, antitumor and anti-HIV activities, etc. \[[@B3-molecules-21-01146],[@B4-molecules-21-01146]\].

Dimacrolide sesquiterpene pyridine alkaloids (DMSPAs) are a structurally unique class of dihydro-β-agarofuran sesquiterpenoids. They were characterized by a polyhydroxylated dihydroagarofuran core and two dicarboxylic acid derivatives linked via four ester bonds forming two macrocyclic systems. DMSPAs are a rare class of compounds naturally occurring in a limited number of plants, such as cathedulin E3 \[[@B5-molecules-21-01146],[@B6-molecules-21-01146],[@B7-molecules-21-01146],[@B8-molecules-21-01146]\], cathedulin E4 \[[@B5-molecules-21-01146],[@B6-molecules-21-01146],[@B7-molecules-21-01146],[@B8-molecules-21-01146]\], cathedulin-K19 \[[@B9-molecules-21-01146]\], and cathedulin-K20 \[[@B9-molecules-21-01146]\] from *Catha edulis* (Forsk), triptonine A \[[@B10-molecules-21-01146],[@B11-molecules-21-01146]\] and triptonine B \[[@B10-molecules-21-01146],[@B11-molecules-21-01146]\] from *Tripterygium hypoglaucum*, and tripterygiumine A \[[@B12-molecules-21-01146]\] from *Tripterygium wilfordii*. Moreover, triptonine B has been reported to inhibit HIV replication with EC~50~ value \< 0.10 μg/mL in H9 lymphocytes with a significant therapeutic index (TI) value (TI \> 1000) \[[@B11-molecules-21-01146]\].

*Tripterygium regelii* is distributed throughout northeast China, Korea and Japan \[[@B13-molecules-21-01146]\], and has been used as a folk medicine in China to treat rheumatoid arthritis, jaundice, swelling, etc. \[[@B14-molecules-21-01146]\]. A few earlier phytochemical studies on this plant showed the presence of diterpenoids \[[@B15-molecules-21-01146]\], triterpenoids \[[@B16-molecules-21-01146],[@B17-molecules-21-01146],[@B18-molecules-21-01146],[@B19-molecules-21-01146],[@B20-molecules-21-01146]\] and alkaloids \[[@B21-molecules-21-01146],[@B22-molecules-21-01146]\]. Recently, twelve new dihydro-β-agarofuran sesquiterpenoids and three new triterpenoids have been isolated and identified from the stems of *T. regelii* in our laboratory \[[@B23-molecules-21-01146],[@B24-molecules-21-01146]\]. During our ongoing search for secondary metabolites from *T. regelii*, this phytochemical investigation was extended, resulting in the isolation of two new DMSPAs **1** and **2** ([Figure 1](#molecules-21-01146-f001){ref-type="fig"}). Herein, we report the isolation and structural elucidation of both compounds, as well as their inhibitory effect on proliferation of human rheumatoid arthritis synovial fibroblast (MH7A) cells.

2. Results and Discussion {#sec2-molecules-21-01146}
=========================

Compound **1** was obtained as a white amorphous powder. The molecular formula of C~38~H~45~NO~16~ was deduced from an \[M + H\]^+^ ion peak at *m*/*z* 772.2820 (calcd. for C~38~H~46~NO~16~, 772.2811) in the HRESIMS. Its UV spectrum showed absorption bands at λ~max~ 231 and 253 nm, indicating the presence of aromatic rings. In the ^1^H-NMR spectroscopic data of **1** ([Table 1](#molecules-21-01146-t001){ref-type="table"}), resonances for six oxygenated methines \[δ~H~ 6.61 (1H, s, H-6), 5.50 (1H, dd, *J* = 6.0, 3.6 Hz, H-8), 4.75 (1H, d, *J* = 3.0 Hz, H-3), 4.42 (1H, d, *J* = 6.0 Hz, H-9), 4.19 (1H, d, *J* = 3.6 Hz, H-1) and 3.84 (1H, dd, *J* = 3.6, 3.0 Hz, H-2)\], one methine \[δ~H~ 2.62 (1H, d, *J* = 3.6 Hz, H-7)\], two oxygenated methylenes \[δ~H~ 5.96 and 3.84 (each 1H, d, *J* = 11.4 Hz, H~2~-13); 5.62 and 4.76 (each 1H, d, *J* =14.4 Hz, H~2~-15)\], one hydroxyl proton \[4.64 (1H, s), OH-4\], two tertiary methyl groups \[δ~H~ 1.61 and 1.58 (each 3H, s, H~3~-12 and H~3~-14)\] and an acetyl group \[δ~H~ 2.12 (3H, s, OAc-6)\] indicated the presence of a polyoxygenated dihydro-β-agarofuran sesquiterpene unit \[[@B23-molecules-21-01146],[@B25-molecules-21-01146],[@B26-molecules-21-01146],[@B27-molecules-21-01146],[@B28-molecules-21-01146]\]. An evoninic acid moiety \[[@B25-molecules-21-01146],[@B26-molecules-21-01146],[@B27-molecules-21-01146],[@B28-molecules-21-01146],[@B29-molecules-21-01146]\] was deduced by the signals for a 2,3-disubstituted pyridine \[δ~H~ 8.66 (1H, dd, *J* = 4.8, 1.8 Hz, H-6′), 8.16 (1H, dd, *J* = 7.8, 1.8 Hz, H-4′) and 7.39 (1H, dd, *J* = 7.8, 4.8 Hz, H-5′)\], two methines \[δ~H~ 4.62 (1H, qd, *J* = 6.6, 1.2 Hz, H-7′) and 2.44 (1H, br q, *J* = 6.6 Hz, H-8′)\], and two secondary methyl groups \[δ~H~ 1.36 and 1.13 (each 3H, d, *J* = 6.6 Hz, H~3~-9′ and H~3~-10′)\]. The remaining signals for a 2,3-disubstituted furan \[δ~H~ 7.42 (1H, d, *J* = 1.8 Hz, H-8″), 6.73 (1H, d, *J* = 1.8 Hz, H-7″)\], a methine \[δ~H~ 2.50 (1H, m, H-2″)\], two mehylenes \[δ~H~ 3.77 (1H, m, H-4″a) and 2.96 (1H, ddd, *J* = 14.4, 7.2, 4.2 Hz, H-4″b); 2.06 and 1.91 (each 1H, m, H~2~-3″)\], and one secondary methyl group \[δ~H~ 1.14 (3H, d, *J* = 7.2 Hz, H-10″)\] were attributed to a 2-(3′-carboxybutyl)-3-furanoic acid unit in the ^1^H-NMR spectrum. The ^13^C-NMR spectroscopic data ([Table 1](#molecules-21-01146-t001){ref-type="table"}) along with DEPT and HSQC spectra showed the presence of the units mentioned above in **1**. These characteristic NMR data suggested **1** to be a dimacrolide sesquiterpene pyridine alkaloid \[[@B5-molecules-21-01146],[@B6-molecules-21-01146],[@B7-molecules-21-01146],[@B8-molecules-21-01146],[@B9-molecules-21-01146],[@B10-molecules-21-01146],[@B11-molecules-21-01146],[@B12-molecules-21-01146]\]. The ^1^H- and ^13^C-NMR data ([Table 1](#molecules-21-01146-t001){ref-type="table"}) of **1** were similar to those of triptonine A \[[@B10-molecules-21-01146]\], previously isolated from *T. hypoglaucum*, except for the following two differences: one difference was the different chemical shifts of C-5″, C-6″, C-7″ and C-8″ in **1** from those in triptonine A due to the presence of a furan group in the second macrocyclic ring system in **1**. The 2-(3′-carboxybutyl)-3-furanoic acid unit was disclosed from ^1^H-^1^H COSY correlations of H~3~-10″/H~1~-2″/H~2~-3″/H~2~-4″ and H-7″/H-8″, and the key HMBC correlations from H-3″ and H-10 ″ to C-1″, from H-4″ to C-6″, from H-7″ to C-5″, C-6″, C-8″ and C-9″, and from H-8″ to C-5″, C-6″ and C-7″ ([Figure 2](#molecules-21-01146-f002){ref-type="fig"}A). The linkages of 2-(3′-carboxybutyl)-3-furanoic acid unit and dihydro-β-agarofuran sesquiterpene core were via C-8−O−C-1″ and C-15−O−C-9″, as deduced from the key HMBC correlations from H-8 (δ~H~ 5.50) and H~2~-15 (δ~H~ 5.62 and 4.76) to the carbonyl carbons (δ~C~ 177.1, C-1″) and (δ~C~ 166.2, C-9″), respectively. The other key difference was the absence of three acetyl groups and the upfield shifts of H-1 (δ~H~ 4.19), H-2 (δ~H~ 3.84) and H-9 (δ~H~ 4.42) relative to those (δ~H~ 5.46, 5.15, and 5.25, respectively) in triptonine A, which suggested deacetylation of the C-1, C-2 and C-9 in **1**. Therefore, the proposed planar structure of **1** was established and further confirmed by the ^1^H-^1^H COSY and HMBC analyses ([Figure 2](#molecules-21-01146-f002){ref-type="fig"}A).

The relative configuration of the dihydro-β-agarofuran sesquiterpene core in **1** was assigned by the NOESY correlations ([Figure 2](#molecules-21-01146-f002){ref-type="fig"}B) and coupling constant. The NOE correlations of H-1/H-9, H-9/H~3~-12 and H~3~-12/H-8 suggested that these protons were on the same face. NOE effects of H~3~-14/H-3, H~3~-14/H-6 and H~3~-14/H~2~-15 were observed, showing that these protons were on the other face. The small coupling constant of *J*~1,2~ = 3.6 Hz between H-1 and H-2 indicated that the H-2 was equatorial. These data revealed that the relative configuration of the dihydro-β-agarofuran sesquiterpene core in **1** was identical to that of triptonine A \[[@B10-molecules-21-01146]\] and the related compounds \[[@B12-molecules-21-01146],[@B27-molecules-21-01146],[@B28-molecules-21-01146]\]. The relative configurations of the groups at two macrocyclic rings were determined by comparison of the NMR spectroscopic data with those of triptonine A \[[@B10-molecules-21-01146]\], which was established by X-ray crystallography. As the ^1^H and ^13^C data of **1** were closely similar to those of triptonine A except for positions C-5″, C-6″, C-7″ and C-8″, it could indicate the same relative configurations at C-7′, C-8′ and C-2″ in the macrocyclic rings. Therefore, compound **1** was identified as shown in [Figure 1](#molecules-21-01146-f001){ref-type="fig"}, and given a trivial name of dimacroregeline A.

Compound **2** was isolated as a white amorphous powder. The molecular formula was determined as C~40~C~47~NO~18~ on the basis of a protonated molecule at *m*/*z* 830.2876 \[M + H\]^+^ (calcd for C~40~C~48~NO~18~, 830.2866), which was 58.0056 mass units more than that of **1** in the HRESIMS. The ^1^H and ^13^C-NMR spectroscopic data of **2** ([Table 1](#molecules-21-01146-t001){ref-type="table"}) were closely similar to those of **1** except for the absence of C-4″ methylene group and the presence of an additional oxygenated methine (δ~H~ 6.89, δ~C~ 68.0, CH-4″) and an extra acetyl group (δ~H~ 1.96, δ~C~ 171.6 and 20.9). The methylene group (δ~H~ 3.77 and 2.96) at C-4″ in **1** was displaced by the oxygenated methine (δ~H~ 6.89, H-4″) in **2**, supported by the observation of HMBC correlation from the oxygenated methine (δ~H~ 6.89) to the carbon signal (δ~C~ 37.9) at C-3″ in **2**. The acetyl group (δ~H~ 1.96, δ~C~ 171.6 and 20.9) was allocated to C-4″ in **2**, as evidenced from the HMBC correlation from H-4″ signal (δ~H~ 6.89) to the carbonyl carbon (δ~C~ 171.6) of the acetyl group. Thus, compound **2** was elucidated as shown in [Figure 1](#molecules-21-01146-f001){ref-type="fig"}, and named dimacroregeline B.

So far, only seven dimacrolide sesquiterpene pyridine alkaloids \[[@B5-molecules-21-01146],[@B6-molecules-21-01146],[@B7-molecules-21-01146],[@B8-molecules-21-01146],[@B9-molecules-21-01146],[@B10-molecules-21-01146],[@B11-molecules-21-01146],[@B12-molecules-21-01146]\] have been isolated from plants. Compounds **1** and **2** represent the first example of dimacrolide sesquiterpene pyridine alkaloids bearing an extra furan ring in their second macrocyclic ring system. The HRMS, UV, NMR and CD spectra of compounds **1** and **2** were shown in the supplementary materials ([Figures S1--S18](#app1-molecules-21-01146){ref-type="app"}).

Over the past several decades, many monomacrolide sesquiterpene pyridine alkaloids have been identified from the plants in the family Celastraceae, especially *Tripterygium* \[[@B3-molecules-21-01146],[@B4-molecules-21-01146]\], the proposed biosynthetic pathways for dihydro-β-agarofuran sesquiterpene unit and pyridine dicarboxylic acid moiety have been disclosed \[[@B9-molecules-21-01146],[@B30-molecules-21-01146],[@B31-molecules-21-01146]\]. The biosynthetic pathway of 2-(3′-carboxybutyl)-3-furanoic acid unit was proposed as shown in [Scheme 1](#molecules-21-01146-sch001){ref-type="scheme"}, since this unit was reported in nature for the first time. The 3-furanoic acid residue is regarded as its biosynthetic precursor, which could generate this unit via prenylation under catalysis in plants \[[@B32-molecules-21-01146]\].

It is well known that activated synovial fibroblasts play a crucial role in the pathogenesis of rheumatoid arthritis (RA), which could result in the cartilage destruction and synovial inflammation \[[@B33-molecules-21-01146],[@B34-molecules-21-01146],[@B35-molecules-21-01146]\]. The inhibition of the synovial fibroblast proliferation is considered as a promising treatment for RA. Thus, compounds **1** and **2** were evaluated for anti-proliferative activity against human rheumatoid arthritis synovial fibroblast cell line (MH7A). As the result ([Table 2](#molecules-21-01146-t002){ref-type="table"}), compound **2** inhibited proliferation of MH7A cells (*p* \< 0.05) by 13.3% at the concentration of 20 μM compared with the vehicle control.

3. Materials and Methods {#sec3-molecules-21-01146}
========================

3.1. General Procedures {#sec3dot1-molecules-21-01146}
-----------------------

Optical rotations and ultraviolet (UV) spectra were recorded on a Rudolph Research Analytical Autopol I automatic polarimeter (Rudolph Research Analytical, Hackettstown, NJ, USA) and a DU^®^ 800 spectrophotometer (Beckman Coulter, Fullerton, CA, USA), respectively. Circular dichroism spectra were measured on a Jasco J1500 CD spectrometer (Jasco Corperation, Tokyo, Japan). Nuclear magnetic resonance (NMR) spectra were acquired with an Ascent 600 NMR spectrometer at 600 MHz for ^1^H-NMR and 150 MHz for ^13^C-NMR (Bruker, Zurich, Switzerland). The samples dissolved in CD~3~OD with residual solvent as an internal reference. HRMS spectra were performed on a 6230 electrospray ionization (ESI) time-of-flight (TOF) mass spectrometer (Agilent, Santa Clara, CA, USA) in the positive ion mode. Medium pressure liquid chromatography (MPLC) was carried out on a Sepacore Flash Chromatography System (Buchi, Flawil, Switzerland) using a flash column (460 × 36 mm, i.d., Buchi) packed with Bondapak Waters ODS (40--63 μm, Waters, Milford, MA, USA). Preparative HPLC was conducted on a Waters liquid chromatography system coupled with 1525 Binary HPLC Pump and 2489 UV/Visible detector using a Waters Xbridge Prep C~8~ column (10 × 250 mm, 5 μm). Semi-preparative HPLC was performed on an Agilent 1100 liquid chromatography system equipped with a quaternary pump and a diode array detector (DAD) using a Waters Xbridge Prep C~18~ column (10 × 250 mm, 5 μm). Silica gel (40--60 μm, Grace, Columbia, MD, USA) was used for column chromatography. Thin layer chromatography (TLC) was performed on precoated silica gel 60 F~254~ plates and TLC silica gel 60 RP-18 F~254S~ plates (200 µm thick, Merck KGaA, Darmstadt, Germany).

3.2. Plant Material {#sec3dot2-molecules-21-01146}
-------------------

The stems of *T. regelii* were collected from Changbai Mountain in Jilin Province, China, in October 2012, and authenticated by Dr. Liang Xu, School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, China. A voucher specimen (No. MUST-TR201210) has been deposited at State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.

3.3. Extraction and Isolation {#sec3dot3-molecules-21-01146}
-----------------------------

The air-dried and crushed stems of *T. regelii* (8.0 kg) were extracted three times with MeOH (64 L) under ultrasound at room temperature for 1 h. A dark brown residue was obtained after removing the solvent under reduced pressure, which was suspended in H~2~O, and then partitioned with *n*-hexane, EtOAc and *n*-butanol. The EtOAc-soluble extract (150.0 g) was chromatographed over a silica gel column and eluted with petroleum ether--acetone (100:0--35:65, *v*/*v*) to give thirteen fractions (Fr. 1--Fr.13). The Fr.12 (9.0 g) was separated by MPLC with a gradient of MeOH--H~2~O (5:95--100:0, 50 mL/min) to afford six fractions (Fr.12-1--Fr.12-6). The Fr.12-5 showed the alkaloid-positive test after spraying with Dragendorff's reagent. Then, Fr.12-5 (350 mg) was separated by preparative HPLC using MeCN--H~2~O (42:58, *v*/*v*) as mobile phase to give eleven fractions (Fr.12-5-1--Fr.12-5-11). Fr.12-5-2 (50 mg) was isolated by semi-preparative HPLC with a MeCN--H~2~O (39:61, *v*/*v*) solvent system to afford compound **2** (1.22 mg) and subfraction 12-5-2-3 (5 mg). Then, the subfraction 12-5-2-3 was further purified by semi-preparative HPLC using MeOH--H~2~O (40:60, *v*/*v*) as mobile phase to yield compound **1** (1.01 mg).

*Dimacroregeline A* (**1**) White amorphous powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ −19.8 (*c* 0.25, MeOH); UV (MeOH) λ~max~ (log ε) 231 (3.95), 253 (3.84) nm; CD (*c* 6.5 × 10^−4^ mol/L, MeOH) λ~max~ (Δε) 200 (+14.60), 216 (sh) (+3.96), 241 (−3.96) nm; ^1^H-NMR (CD~3~OD) and ^13^C-NMR (CD~3~OD) data, see [Table 1](#molecules-21-01146-t001){ref-type="table"}; HRESIMS *m*/*z* 772.2820 \[M + H\]^+^ (calcd for C~38~H~46~NO~16~, 772.2811), HRESIMS *m*/*z* 794.2634 \[M + Na\]^+^ (calcd. for C~38~H~45~NO~16~Na, 794.2631).

*Dimacroregeline B* (**2**) White amorphous powder; ${\lbrack\mathsf{\alpha}\rbrack}_{D}^{25}$ +4.0 (*c* 0.50, MeOH); UV (MeOH) λ~max~ (log ε) 228 (3.98), 260 (3.65) nm; CD (*c* 6.0 × 10^−4^ mol/L, MeOH) λ~max~ (Δε) 233 (+22.64), 245 (+17.36), 276 (−2.90) nm; ^1^H-NMR (CD~3~OD) and ^13^C-NMR (CD~3~OD) data, see [Table 1](#molecules-21-01146-t001){ref-type="table"}; HRESIMS *m*/*z* 830.2876 \[M + H\]^+^ (calcd for C~40~H~48~NO~18~, 830.2866), HRESIMS *m*/*z* 852.2695 \[M + Na\]^+^ (calcd. for C~40~H~47~NO~18~Na, 852.2685).

3.4. Inhibition of Proliferation on MH7A Human Synovial Cells {#sec3dot4-molecules-21-01146}
-------------------------------------------------------------

MH7A cells were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). Cells were cultured in a Dulbecco's modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Invitrogen, Carlsbad, CA, USA) and 1% penicillin-streptomycin (Sigma, St. Louis, MO, USA) at 37 °C in humidified atmosphere containing 5% CO~2~. MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide\] was employed to determine the cell viability as described previously \[[@B36-molecules-21-01146],[@B37-molecules-21-01146]\]. Briefly, 5 × 10^3^ cells/well MH7A cells (total 100 µL) were cultured in triplicate in a 96-well plate with or without 20 μM compounds for 48 h incubation at 37 °C in humidified atmosphere containing 5% CO~2~. MTT (5 mg/mL, 10 µL) was added into each well and incubated for 4 h before terminating the culture. The supernatant was gently removed, and the formazan in each well was dissolved in the lysing solvent (10% sodium dodecyl sulfate (SDS), 50% *N*,*N*-dimethylformamide, pH 7.2). Absorbance at 570 nm was determined using a microplate reader (Infinite 200 PRO, Tecan, Männedorf, Switzerland) from each well on the next day. The percentage of cell viability was calculated using the following formula: Cell viability (%) = (Absorbance of treated with compounds/Absorbance of treated with control vehicle) × 100. Data reported represent three independent experiments. Data are expressed as means ± SEM. One-way ANOVA was used to determine the significance of difference. A value of *p* \< 0.05 was considered statistically significant.
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**Sample Availability:** Samples of the compounds **1** and **2** are available from the authors.
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Click here for additional data file.
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![The chemical structures of compounds **1**, **2** and triptonine A.](molecules-21-01146-g001){#molecules-21-01146-f001}

![The ^1^H-^1^H COSY, key HMBC and selected NOESY correlations of **1**.](molecules-21-01146-g002){#molecules-21-01146-f002}

![Plausible biosynthetic pathway for 2-(3′-carboxybutyl)-3-furanoic acid unit.](molecules-21-01146-sch001){#molecules-21-01146-sch001}
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###### 

^1^H- (600 MHz) and ^13^C- (150 MHz) NMR spectroscopic data for **1** and **2** in CD~3~OD.

  Position   1                            2                                       
  ---------- ---------------------------- ------------- ------------------------- -------------
  1          4.19, d (3.6)                75.4, CH      4.24, d (3.6)             74.9, CH
  2          3.84, dd (3.6, 3.0)          73.0, CH      3.83, dd (3.6, 2.4)       73.0, CH
  3          4.75, d, (3.0) ^a^           80.4, CH      4.79, d (2.4)             80.2, CH
  4                                       72.2, C                                 72.3, C
  5                                       95.3, C                                 94.9, C
  6          6.61, s                      76.6, CH      6.20, s                   78.5, CH
  7          2.62, d (3.6)                51.1, CH      2.94, d (4.2)             50.0, CH
  8          5.50, dd (6.0, 3.6)          72.9, CH      5.44, dd (6.0, 4.2)       73.4, CH
  9          4.42, d (6.0)                73.6, CH      4.43, d (6.0)             73.7, CH
  10                                      54.8, C                                 55.2, C
  11                                      85.1, C                                 84.7, C
  12         1.61, s                      18.4, CH~3~   1.59, s                   18.2, CH~3~
  13 a       5.96, d (11.4)               71.6, CH~2~   5.78, d (11.4)            71.4, CH~2~
  13 b       3.84, d (11.4) ^a^                         3.81, d (11.4)            
  14         1.58, s                      24.1, CH~3~   1.77, d (0.6)             24.6, CH~3~
  15 a       5.62, d (14.4)               63.2, CH~2~   5.21, d (14.4)            64.1, CH~2~
  15 b       4.76, d (14.4) ^a^                         5.01, d (14.4)            
  2′                                      165.7, C                                165.3, C
  3′                                      127.2, C                                127.4, C
  4′         8.16, dd (7.8, 1.8)          139.2, CH     8.13, dd (7.8, 1.8)       139.0, CH
  5′         7.39, dd (7.8, 4.8)          122.8, CH     7.39, dd (7.8, 4.8)       122.8, CH
  6′         8.66, dd (4.8, 1.8)          152.4, CH     8.66, dd (4.8, 1.8)       152.4, CH
  7′         4.62, qd (6.6, 1.2) ^a^      37.6, CH      4.57, qd (6.6, 1.2) ^a^   37.7, CH
  8′         2.44, br q (6.6)             46.3, CH      2.46, qd (6.6, 1.2)       46.2, CH
  9′         1.36, d (6.6)                12.0, CH~3~   1.36, d (6.6)             12.2, CH~3~
  10′        1.13, d (6.6)                9.8, CH~3~    1.16, d (6.6)             9.9, CH~3~
  11′                                     175.9, C                                175.9, C
  12′                                     170.1, C                                170.0, C
  1″                                      177.1, C                                176.5, C
  2″         2.50, m                      38.0, CH      2.16, m                   35.5, CH
  3″ a       2.06, m                      33.2, CH~2~   2.36, td (12.6, 4.8)      37.9, CH~2~
  3″ b       1.91, m                                    2.25, td (12.6, 1.8)      
  4″ a       3.77, m                      26.8, CH~2~   6.89, dd (12.6, 4.8)      68.0, CH
  4″ b       2.96, ddd (14.4, 7.2, 4.2)                                           
  5″                                      161.3, C                                154.3, C
  6″                                      116.0, C                                119.9, C
  7″         6.73, d (1.8)                113.4, CH     6.80, d (1.8)             113.5, CH
  8″         7.42, d (1.8)                142.3, CH     7.58, d (1.8)             144.1, CH
  9″                                      166.2, C                                165.6, C
  10″        1.14, d (7.2)                17.4, CH~3~   1.10, d (6.6)             17.7, CH~3~
  OH-4       4.64, s ^a^                                4.57, s ^a^               
  OAc-6      2.12, s                      21.5, CH~3~   2.09, s                   21.7, CH~3~
                                          171.3, C                                171.9, C
  OAc-4″                                                1.96, s                   20.9, CH~3~
                                                                                  171.6, C

^a^ The overlapped signals were assigned from ^1^H-^1^H COSY, HSQC, and HMBC spectra.

molecules-21-01146-t002_Table 2

###### 

Effect of compounds **1** and **2** on the viability of MH7A cell.

  Compounds ^\#^    Cell Viability (%) (*n* = 3)   Inhibition Rate (%)
  ----------------- ------------------------------ ---------------------
  Vehicle control   100 ± 5.9                      0
  **1**             94.6 ± 5.4                     5.4 ± 5.4
  **2**             86.7 ± 5.2 \*                  13.3 ± 5.2 \*

\* There was a significant difference (*p* \< 0.05) between the group treated with compound **2** and the control group treated with the vehicle; ^\#^ Compounds **1** and **2** were tested at the concentration of 20 µM.
